Skip to main content
Carasent logo

Carasent — Investor Relations & Filings

Ticker · CARA ISIN · NO0010123060 LEI · 5967007LIEEXZXI9ZS60 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 635 across all filing types
Latest filing 2020-12-10 Board/Management Inform…
Country NO Norway
Listing OL CARA

About Carasent

https://carasent.com/

Carasent is a health technology group focused on enhancing efficiency and quality in the healthcare sector. The company develops and provides mission-critical, cloud-based software solutions, with a primary focus on Electronic Health Record (EHR) and Electronic Medical Record (EMR) systems, often delivered as Software as a Service (SaaS). With over 30 years of experience, Carasent also offers a suite of integrated ecosystem services designed to automate and streamline clinical and administrative workflows. By integrating its core platforms with proprietary and third-party applications, the company creates seamless processes that reduce administrative burdens for customers in the healthcare, rehabilitation, and occupational health sectors.

Recent filings

Filing Released Lang Actions
Carasent ASA: Changes in Board and Management
Board/Management Information Classification · 100% confidence The document explicitly details proposed changes to the Board of Directors (Anna Kinberg Batra and Jesper Jannerberg) and the appointment of a new CEO (Dennis Höjer). This content directly aligns with the definition of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management. The filing type code for this is MANG.
2020-12-10 Norwegian
Carasent ASA: Changes in Board and Management
Board/Management Information Classification · 100% confidence The document explicitly announces changes in the company's leadership structure, specifically proposing new Board members (Anna Kinberg Batra and Jesper Jannerberg) for an upcoming meeting and announcing the appointment of a new CEO (Dennis Höjer). This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-12-10 English
Carasent ASA: Carasent ASA acquires Avans Soma AS
M&A Activity Classification · 98% confidence The document is a press release dated December 10, 2020, announcing that Carasent ASA has acquired Avans Soma AS. It details the strategic rationale, financial metrics of the acquired company (revenues, EBITDA, ARR), the purchase price (NOK 122.5 million), and the settlement structure (cash and shares). This content directly relates to a significant corporate transaction involving the acquisition of another company. Based on the provided definitions, this falls under 'M&A Activity' (Code: TAR). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it specifically concerns a merger/takeover proposal/completion.
2020-12-10 Norwegian
Carasent ASA: Carasent ASA acquires Avans Soma AS
M&A Activity Classification · 99% confidence The document is a press release dated December 10, 2020, announcing that Carasent ASA has acquired Avans Soma AS. It details the strategic rationale, financial metrics of the acquired company (revenues, EBITDA, ARR), the purchase price, and the settlement structure (cash and shares). This type of announcement, detailing a significant corporate transaction like an acquisition, falls under the category of M&A Activity (TAR). It is not a standard regulatory filing like 10-K, an earnings release (ER), or a general regulatory announcement (RNS), as it specifically concerns a merger/takeover proposal/activity.
2020-12-10 English
CARASENT ASA: APPROVED PROSPECTUS AND LISTING OF SHARES
Share Issue/Capital Change Classification · 95% confidence The document explicitly titles itself as a "Prospectus" and details the listing of new shares following a private placement. It references compliance with the Norwegian Securities Trading Act and the EU Prospectus Regulation, and mentions approval by the Norwegian FSA. A prospectus is a formal legal document required for offering securities to the public or admitting them to trading on a regulated market. This content strongly aligns with the purpose of a document related to capital raising and listing, which falls under the scope of financing activities or a specific offering document. Given the options, while it is a comprehensive document detailing capital structure and financial information, its primary function as a legal document for a new share listing/admission to trading is best captured by the 'Capital/Financing Update' (CAP) category, as it details the issuance and listing of new shares. However, a Prospectus is a very specific type of offering document. Since 'CAP' covers fundraising/financing activities, and this document is the core legal document enabling the listing of newly issued shares, it fits best there, although it contains elements of an Annual Report (financials) and Share Issue (SHA). Given the context of a listing prospectus, CAP is the most appropriate fit among the provided codes for a document detailing a capital increase and subsequent listing.
2020-12-10 Norwegian
CARASENT ASA: APPROVED PROSPECTUS AND LISTING OF SHARES
Share Issue/Capital Change Classification · 95% confidence The document is titled "CARASENT ASA: APPROVED PROSPECTUS AND LISTING OF SHARES" and discusses the approval of a prospectus by the Norwegian Financial Supervisory Authority (NFSA) for the listing of previously unlisted shares resulting from a private placement. This directly relates to capital structure changes, share issuance, and the subsequent listing process. While it involves a prospectus, the core action being announced is the final step of a financing/share issuance event leading to listing. The most fitting category is 'Capital/Financing Update' (CAP) as it details the successful completion and listing aspect of a private placement. It is not a general regulatory filing (RNS) because it is highly specific to a financing event, nor is it a share issue announcement (SHA) which usually precedes the listing approval, although it is closely related. Given the focus on the successful placement and subsequent listing approval, CAP is the best fit.
2020-12-10 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.